Human DNA polymerase η activity and translocation is regulated by phosphorylation

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 43, 2008, Pages 16578-16583

  Chen, Yih Wen ^a   Cleaver, James E ^b   Hatahet, Zafer ^c   Honkanen, Richard E ^d   Chang, Jang Yang ^e   Yen, Yun ^f   Chou, Kai Ming ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NORTHWESTERN STATE UNIVERSITY   (United States)

^d UNIVERSITY OF SOUTH ALABAMA   (United States)

^e NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^f CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Lesion bypass; Xeroderma pigmentosum variant

Indexed keywords

ATR PROTEIN; CAFFEINE; CALPHOSTIN C; CISPLATIN; DNA DIRECTED DNA POLYMERASE ETA; GEMCITABINE; PROTEIN KINASE C; SMALL INTERFERING RNA;

ARTICLE; CELL LINE; CONTROLLED STUDY; DNA REPLICATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME REGULATION; GENE TRANSLOCATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MUTANT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SITE DIRECTED MUTAGENESIS; ULTRAVIOLET IRRADIATION; WILD TYPE; XERODERMA PIGMENTOSUM;

CAFFEINE; CELL CYCLE PROTEINS; CELL LINE; DNA DAMAGE; DNA REPLICATION; DNA-DIRECTED DNA POLYMERASE; HUMANS; MUTATION, MISSENSE; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN-SERINE-THREONINE KINASES; RNA, SMALL INTERFERING; ULTRAVIOLET RAYS;

EID: 55949125726     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0808589105     Document Type: Article

References (51)

1. Cleaver JE (2005) Cancer in xeroderma pigmentosum and related disorders of DNA repair. Nat Rev Cancer 5:564-573.
2. Lehmann AR (2003) DNA repair-deficient diseases, xeroderma pigmentosum, Cockayne syndrome, and trichothiodystrophy. Biochimie 85:1101-1111.
3. Masutani C, et al. (1999) The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase eta. Nature 399:700-704.
4. Masutani C, et al. (1999) Xeroderma pigmentosum variant (XP-V) correcting protein from HeLa cells has a thymine dimer bypass DNA polymerase activity. EMBO J 18:3491-3501.
5. Cleaver JE, et al. (1980) Similar defects in DNA repair and replication in the pigmented xerodermoid and the xeroderma pigmentosum variants. Carcinogenesis 1:647-655.
6. Wang YC, Maher VM, Mitchell DL, McCormick JJ (1993) Evidence from mutation spectra that the UV hypermutability of xeroderma pigmentosum variant cells reflects abnormal, error-prone replication on a template containing photoproducts. Mol Cell Biol 13:4276-4283.
7. Lehmann AR (2002) Replication of damaged DNA in mammalian cells: New solutions to an old problem. Mutat Res 509:23-34.
8. Chen YW, Cleaver JE, Hanaoka F, Chang CF, Chou KM (2006) A novel role of DNA polymerase eta in modulating cellular sensitivity to chemotherapeutic agents. Mol Cancer Res 4:257-265.
9. Franklin A, Milburn PJ, Blanden RV, Steele EJ (2004) Human DNA polymerase-eta, an A-T mutator in somatic hypermutation of rearranged immunoglobulin genes, is a reverse transcriptase. Immunol Cell Biol 82:219-225.
10. McIlwraith MJ, et al. (2005) Human DNA polymerase eta promotes DNA synthesis from strand invasion intermediates of homologous recombination. Mol Cell 20:783-792.
11. de Feraudy S, et al. (2007) Pol eta is required for DNA replication during nucleotide deprivation by hydroxyurea. Oncogene 26:5713-5721.
12. Matsuda T, Bebenek K, Masutani C, Hanaoka F, Kunkel TA (2000) Low fidelity DNA synthesis by human DNA polymerase-eta. Nature 404:1011-1013.
13. Kannouche P, et al. (2001) Domain structure, localization, and function of DNA polymerase eta, defective in xeroderma pigmentosum variant cells. Genes Dev 15:158-172.
14. Godoy VG, Jarosz DF, Walker FL, Simmons LA, Walker GC (2006) Y-family DNA polymerases respond to DNA damage-independent inhibition of replication fork progression. EMBO J 25:868-879.
15. Kannouche PL, Wing J, Lehmann AR (2004) Interaction of human DNA polymerase eta with monoubiquitinated PCNA: A possible mechanism for the polymerase switch in response to DNA damage. Mol Cell 14:491-500.
16. Haracska L, Unk I, Prakash L, Prakash S (2006) Ubiquitylation of yeast proliferating cell nuclear antigen and its implications for translesion DNA synthesis. Proc Natl Acad Sci USA 103:6477-6482.
17. Shechter D, Costanzo V, Gautier J (2004) Regulation of DNA replication by ATR: Signaling in response to DNA intermediates. DNA Repair (Amst) 3:901-908.
18. Bomgarden RD, et al. (2006) Opposing effects of the UV lesion repair protein XPA and UV bypass polymerase eta on ATR checkpoint signaling. EMBO J 25:2605-2614.
19. Cordeiro-Stone M, Makhov AM, Zaritskaya LS, Griffith JD (1999) Analysis of DNA replication forks encountering a pyrimidine dimer in the template to the leading strand. J Mol Biol 289:1207-1218.
20. Cordeiro-Stone M, Zaritskaya LS, Price LK, Kaufmann WK (1997) Replication fork bypass of a pyrimidine dimer blocking leading strand DNA synthesis. J Biol Chem 272:13945-13954.
21. Domon M, Rauth AM (1969) Ultraviolet-light irradiation of mouse L cells: Effects on cells in the DNA synthesis phase. Radiat Res 40:414-429.
22. Lehmann AR, Kirk-Bell S, Mayne L (1979) Abnormal kinetics of DNA synthesis in ultraviolet light-irradiated cells from patients with Cockayne's syndrome. Cancer Res 39:4237-4241.
23. Chaney SG, Campbell SL, Bassett E, Wu Y (2005) Recognition and processing of cisplatin- and oxaliplatin-DNA adducts. Crit Rev Oncol Hematol 53:3-11.
24. Hall-Jackson CA, Cross DA, Morrice N, Smythe C (1999) ATR is a caffeine-sensitive, DNA-activated protein kinase with a substrate specificity distinct from DNA-PK. Oncogene 18:6707-6713.
25. Kaufmann WK, et al. (2003) Caffeine and human DNA metabolism: The magic and the mystery. Mutat Res 532:85-102.
26. Sarkaria JN, et al. (1999) Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Cancer Res 59:4375-4382.
27. Goth R, Cleaver JE (1976) Metabolism of caffeine to nucleic acid precursors in mammalian cells. Mutat Res 36:105-114.
28. Koivunen J, Aaltonen V, Peltonen J (2006) Protein kinase C (PKC) family in cancer progression. Cancer Lett 235:1-10.
29. Denning MF, Wang Y, Nickoloff BJ, Wrone-Smith T (1998) Protein kinase Cdelta is activated by caspase-dependent proteolysis during ultraviolet radiation-induced apoptosis of human keratinocytes. J Biol Chem 273:29995-30002.
30. Denning MF, et al. (2002) Caspase activation and disruption of mitochondrial membrane potential during UV radiation-induced apoptosis of human keratinocytes requires activation of protein kinase C. Cell Death Differ 9:40-52.
31. Bruns RF, et al. (1991) Inhibition of protein kinase C by calphostin C is light-dependent. Biochem Biophys Res Commun 176:288-293.
32. Gopalakrishna R, Chen ZH, Gundimeda U (1992) Irreversible oxidative inactivation of protein kinase C by photosensitive inhibitor calphostin C. FEBS Lett 314:149-154.
33. Jarvis WD, Turner AJ, Povirk LF, Traylor RS, Grant S (1994) Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells by pharmacological inhibitors of protein kinase C. Cancer Res 54:1707-1714.
34. Kobayashi E, Nakano H, Morimoto M, Tamaoki T (1989) Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 159:548-553.
35. Svetlov S, Nigam S (1993) Calphostin C, a specific protein kinase C inhibitor, activates human neutrophils: Effect on phospholipase A2 and aggregation. Biochim Biophys Acta 1177:75-78.
36. Guo S, et al. (2006) Regulation of replication protein A functions in DNA mismatch repair by phosphorylation. J Biol Chem 281:21607-21616.
37. Hernandez-Pigeon H, et al. (2005) hMutS alpha is protected from ubiquitin-proteasome-dependent degradation by atypical protein kinase C zeta phosphorylation. J Mol Biol 348:63-74.
38. Yang J, et al. (2004) ATM and ATR: Sensing DNA damage. World J Gastroenterol 10:155-160.
39. Berra E, et al. (1997) Positioning atypical protein kinase C isoforms in the UV-induced apoptotic signaling cascade. Mol Cell Biol 17:4346-4354.
40. D'Costa AM, Denning MF (2005) A caspase-resistant mutant of PKC-delta protects keratinocytes from UV-induced apoptosis. Cell Death Differ 12:224-232.
41. Hussaini IM, et al. (2002) Protein kinase C-eta regulates resistance to UV- and gamma-irradiation-induced apoptosis in glioblastoma cells by preventing caspase-9 activation. Neuro Oncol 4:9 -21.
42. Yoshida K, Wang HG, Miki Y, Kufe D (2003) Protein kinase Cdelta is responsible for constitutive and DNA damage-induced phosphorylation of Rad9. EMBO J 22:1431-1441.
43. Broughton BC, et al. (2002) Molecular analysis of mutations in DNA polymerase eta in xeroderma pigmentosum-variant patients. Proc Natl Acad Sci USA 99:815-820.
44. Laposa RR, Feeney L, Cleaver JE (2003) Recapitulation of the cellular xeroderma pigmentosum-variant phenotypes using short interfering RNA for DNA polymerase H. Cancer Res 63:3909-3912.
45. Lehmann AR, et al. (1977) Repair of ultraviolet light damage in a variety of human fibroblast cell strains. Cancer Res 37:904-910.
46. Limoli CL, Giedzinski E, Cleaver JE (2005) Alternative recombination pathways in UV-irradiated XP variant cells. Oncogene 24:3708-3714.
47. Watanabe K, et al. (2004) Rad18 guides poleta to replication stalling sites through physical interaction and PCNA monoubiquitination. EMBO J 23:3886-3896.
48. Yuasa MS, et al. (2006) A human DNA polymerase eta complex containing Rad18, Rad6 and Rev1; proteomic analysis and targeting of the complex to the chromatin-bound fraction of cells undergoing replication fork arrest. Genes Cells 11:731-744.
49. Cleaver JE, et al. (2002) Polymerase eta and p53 jointly regulate cell survival, apoptosis and Mre11 recombination during S phase checkpoint arrest after UV irradiation. DNA Repair (Amst) 1:41-57.
50. Thakur M, et al. (2001) DNA polymerase eta undergoes alternative splicing, protects against UV sensitivity and apoptosis, and suppresses Mre11-dependent recombination, Genes Chromosomes Cancer 32:222-235.
51. Cleaver JE, Thomas GH (1988) Rapid diagnosis of sensitivity to ultraviolet light in fibroblasts from dermatologic disorders, with particular reference to xeroderma pigmentosum. J Invest Dermatol 90:467-471.